Rank | Title of the publication/first author/publishing year/publishing journal | Citation rate |
---|---|---|
1 | Effect of risedronate on the risk of hip fracture in elderly women/McClung/2001/The New England Journal of Medicine | 1321 |
2 | Zoledronic acid and clinical fractures and mortality after hip fracture/Lyles/2007/The New England Journal of Medicine | 1057 |
3 | Predictive value of BMD for hip and other fractures/Olof/2005/Journal of Bone and Mineral Research | 866 |
4 | Long-term proton pump inhibitor therapy and risk of hip fracture/Yang/2006/The Journal of the American Medical Association | 745 |
5 | Incidence and Mortality of Hip fractures in the United States/Braur/2009/The Journal of the American Medical Association | 695 |
6 | The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women/Kanis/2007/Osteoporosis International | 690 |
7 | Reducing delirium after hip fracture: A randomized trial/Marcantonio/2001/Journal of American Geriatric Society | 689 |
8 | Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study/Roche/2005/British Medical Journal | 658 |
9 | Meta-analysis: Excess Mortality After Hip fracture Among Older Women and Men/Patrick/2010/Annals of Internal Medicine | 600 |
10 | A systematic review of hip fracture incidence and probability of fracture worldwide/Kanis/2012/Osteoporosis International | 530 |